Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Update on NovoRapid PumpCart supply for YpsoPump users
There is a specific issue affecting the NovoRapid PumpCart 1.6ml cartridges, which are used in the mylife YpsoPump insulin pump. This means that while some people may be able to continue using PumpCart for now, others may be asked to switch to using NovoRapid vials with YpsoPump reservoirs, either temporarily or permanently.
If you currently use PumpCart cartridges, your diabetes team may ask you to switch to NovoRapid vials and fill YpsoPump reservoirs manually.
Your GP should now prescribe 10ml vials of NovoRapid instead of PumpCart cartridges.
If you receive your pump supplies from your hospital, they will arrange for you to receive YpsoPump reservoirs.
If you order directly from YpsoMed, we recommend placing an order for YpsoPump reservoirs now, so you have them ready when your PumpCart supply runs out.
YpsoPump reservoirs are made of glass, which means it is safe to pre-fill several in advance.
If you’ve recently switched to using vials and reservoirs, we recommend monitoring your glucose levels more closely during the transition. If you have any concerns, please speak to your diabetes team.
If you’re already using NovoRapid vials to fill your pump, this shortage will not affect you.
You can find more information about the mylife YpsoPump insulin pump reservoirs and watch a video guide on how to use them. For further support, you can contact YpsoMed by email at Info@ypsomed.co.uk or call their customer care team on 0344 856 7820.
We’ll continue to monitor the situation and share updates as they become available. Our priority is to ensure that everyone affected by type 1 diabetes has the information and support they need to manage their treatment with confidence.
Find out about the global research we're funding to find cures and better treatments for T1D.
Get information and advice about living well with type 1.
Join our mission to find cures for T1D and, until then, make life better for people living with it.
If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.
We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.
Breakthrough T1D has helped organise an event hosted by Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’
People living with type 1 diabetes (T1D) across the UK now have more choice in how to manage their condition, with the mylife CamAPS FX app now available on iPhones.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
